Abstract
Hemophilia A is an inherited bleeding disorder caused by a reduced level of factor VIII coagulant activity (FVIII:C) in blood. Bleeding episodes may occur spontaneously in the severe form of hemophilia or after trauma in the milder forms. It is important that patients are diagnosed correctly, which includes placing them into the correct severity category of the disorder so that appropriate treatment can be given. Diagnosis is made by determination of the amount of FVIII:C in the blood, usually using a one-stage factor VIII:C assay. However, approximately one third of patients with mild or moderate hemophilia will have much lower results by the chromogenic assay, with some of them having normal results by the one-stage assay. The chromogenic factor VIII assay is used in some specialized hemophilia reference centers and is recommended for the diagnosis of mild hemophilia A, as this assay is considered to better reflect the severity status of hemophilia patients than the one-stage assay.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Preston FE, Kitchen S, Jennings I, Woods TA, Makris M (2004) SSC/ISTH classification of haemophilia A: can haemophilia center laboratories achieve the new criteria? J Thromb Haemost 2:271–274
Kitchen S, Hayward C, Negrier C, Dargaud Y (2010) New developments in laboratory diagnosis and monitoring. Haemophilia 16(Suppl. 5):61–66
Mackie I, Cooper P, Lawrie A, Kitchen S, Gray E, Laffan M (2013) Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Int J Lab Hematol 35:1–13
Duncan EM, Rodgers SE, McRae SJ (2013) Diagnostic testing for mild haemophilia A in patients with discrepant one-stage, two-stage and chromogenic FVIII:C assays. Semin Thromb Hemost 39:272–282
Parquet-Gernez A, Mazurier C, Goudemand M (1988) Functional and immunological assays of FVIII in 133 haemophiliacs- characterization of a subgroup of patients with mild haemophilia A and discrepancy in 1- and 2-stage assays. Thromb Haemost 59(2):202–206
Duncan EM, Duncan BM, Tunbridge LJ, Lloyd JV (1994) Familial discrepancy between the one-stage and two-stage factor VIII methods in a subgroup of patients with haemophilia A. Br J Haematol 87:846–848
Keeling DM, Sukhu K, Kemball-Cook G, Waseem N, Bagnall R, Lloyd JV (1999) Diagnostic importance of the two-stage FVIII:C assay demonstrated by a case of mild haemophilia associated with His1954Leu substitution in the factor VIII A3 domain. Br J Haematol 105:1123–1126
Rudzki Z, Duncan EM, Casey GJ, Neumann M, Favaloro EJ, Lloyd JV (1996) Mutations in a subgroup of patients with mild haemophilia A and a familial discrepancy between the one-stage and two-stage factor VIII:C methods. Br J Haematol 94:400–406
Rodgers SE, Duncan EM, Sobieraj-Teague M, Lloyd JV (2009) Evaluation of three automated chromogenic FVIII kits for the diagnosis of mild discrepant haemophilia A. Int J Lab Hematol 31(2):180–188
Lippi G, Franchini M, Favaloro EJ (2009) One-stage clotting versus chromogenic assays for assessing recombinant factor VIII; two faces of a haemostasis coin. Blood Coagul Fibrinolysis 20(1):1–3
Peyvandi F, Oldenburg J, Friedman D (2016) A critical appraisal of one-stage and chromogenic assays of factor VIII activity. J Thromb Haemost 14:248–261
Favaloro EJ, Soltani S, McDonald J (2004) Potential laboratory misdiagnosis of hemophilia and von Willebrand disorder owing to cold activation of blood samples for testing. Am J Clin Pathol 122:686–692
Rodgers SE, Lerda NV, Favaloro EJ, Duncan EM, Casey GJ, Quinn DM, Hertzberg M, Lloyd JV (2002) Identification of von Willebrand's disorder type 2N (Normandy) in Australia: a cross-laboratory investigation using different methodologies. Am J Clin Pathol 118:269–276
Zheng C (2013) Combined deficiency of coagulation factors V and VIII: an update. Semin Thromb Hemost 39(6):613–620
Biggs R, Eveling J, Richards G (1955) The assay of antihaemophilic-globulin activity. Brit J Haematol 1:20–34
Denson KWE, Wilkins T (1980) Semi-automation of the two-stage factor VIII assay. Clin Lab Haematol 2:311–316
Schwaab R, Oldenburg J, Kemball-Cook G, Albert T, Juhler C, Hanfland P, Ingerslev J (2000) Assay discrepancy in mild haemophilia A due to a factor VIII missense mutation (Asn694Ile) in a large Danish family. Br J Haematol 109:523–528
Mazurier C, Gaucher C, Jorieux S, Parquet-Gernez A (1997) Mutations in the FVIII gene in seven families with mild haemophilia A. Br J Haematol 96:426–427
Cid AR, Calabuig M, Cortina V, Casana P, Haya S, Moret A et al (2008) One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype. Haemophilia 14:1049–1054
Pipe SW, Saenko EL, Eickhorst AN, Kemball-Cook G, Kaufman RJ (2001) Haemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa. Blood 97(3):685–691
Pipe SW, Eickhorst AN, McKinley SH, Saenko EL, Kaufman RJ (1999) Mild haemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivo. Blood 93(1):176–183
Pavlova A, Delev D, Pezeshkpoor B, Muller J, Oldenburg J (2014) Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays. Thromb Haemost 111:851–861
Rodgers SE, Duncan EM, Barbulescu DM, Quinn DM, Lloyd JV (2006) In vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one-stage and two-stage factor VIII assay results. Br J Haematol 136:138–145
Manco-Johnson MJ, Nuss R, Jacobson LJ (2000) Heparin neutralization is essential for accurate measurement of factor VIII activity and inhibitor assays in blood samples drawn from implanted venous access devices. J Lab Clin Med 136:74–79
Lyall H, Hill M, Westby J, Grimly C, Dolan G (2008) Tyr346-Cys mutation results in factor VIII:C assay discrepancy and a normal bleeding phenotype – is this mild haemophilia A? Haemophilia 14:78–80
Bowyer AE, Goodeve A, Liesner R, Mumford AD, Kitchen S, Makris M (2011) p.Tyr365Cys change in factor VIII: haemophilia A, but not as we know it. Br J Haematol 154(5):618–625
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Rodgers, S., Duncan, E. (2017). Chromogenic Factor VIII Assays for Improved Diagnosis of Hemophilia A. In: Favaloro, E., Lippi, G. (eds) Hemostasis and Thrombosis. Methods in Molecular Biology, vol 1646. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7196-1_21
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7196-1_21
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7194-7
Online ISBN: 978-1-4939-7196-1
eBook Packages: Springer Protocols